Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Sumitomo Dainippon Pharma Co ( (JP:4506) ) is now available.
Sumitomo Pharma Co., Ltd. has announced the refinancing of its existing borrowings through a syndicated loan to stabilize its financial position after a breach of financial covenants. The refinancing involves a term loan and a commitment line totaling 233 billion yen, with minimal expected impact on the company’s financial results for the fiscal year ending March 2025.
More about Sumitomo Dainippon Pharma Co
Sumitomo Pharma Co., Ltd. is a pharmaceutical company based in Osaka, Japan. The company is involved in the development and marketing of pharmaceutical products and has a strategic focus on expanding its market presence through acquisitions and alliances.
YTD Price Performance: 26.40%
Average Trading Volume: 678
Technical Sentiment Signal: Hold
Current Market Cap: $1.91B
See more data about 4506 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue